XM does not provide services to residents of the United States of America.

Clorox lifts annual profit view after beating quarterly estimates on solid demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Clorox lifts annual profit view after beating quarterly estimates on solid demand</title></head><body>

Adds shares in paragraph 11, analyst comment in paragraph 7

By Anuja Bharat Mistry and Jessica DiNapoli

Oct 30 (Reuters) -Clorox CLX.N raised its annual profit forecast after beating quarterly results on Wednesday, betting on robust demand for its cleaning and homecare products, after lapping the impact from a cyberattack last year.

The bleach maker's first-quarter sales surged as its efforts of introducing new and improved products through increased advertising investments across categories helped in attracting value-seeking consumers.

The Pine-Sol maker's volumes jumped after increased promotions further strengthened sales after declining for two consecutive quarters.

The company's net sales rose 38% in the health and wellness business, which contributes 35% to total revenue, while the segment's volumes were up 38 percentage points.

With waning impact from supply chain disruptions caused by the cyberattack, Clorox's margins were bolstered by higher volumes and cost-saving benefits.

"We saw consumption slowing down at the end of last fiscal year," CFO Kevin Jacobsen told Reuters, adding that the company expects consumers to remain under pressure this year.

While discounts and promotions helped Clorox win back customers in the reported quarter, that strategy has its limits as the company, like other CPG brands, "faces a challenging environment in which value-conscious consumers are on the hunt for a deal," Zak Stambor, analyst with eMarketer said.

Clorox's quarterly gross margin expanded 740 basis points to 45.8%.

While Clorox and Colgate-Palmolive CL.N reported an uptick in sales volumes, Kimberly-Clark KMB.N was hit by consumers swapping its pricey goods for cheaper alternatives.

Clorox's revenue rose 27% to $1.76 billion in the quarter ended Sept. 30, beating estimates of an 18.8% increase to $1.65 billion.

Shares of the company, which maintained annual sales forecast, were up about 3% in extended trading.

On an adjusted basis, it earned $1.86 per share, compared with analysts' estimate of $1.39 per share, as per data compiled by LSEG.

For fiscal 2025, the company expects earnings per share to be between $6.65 and $6.90, compared with its prior forecast range of $6.55 to $6.80.



Reporting by Anuja Bharat Mistry in Bengaluru and Jessica DiNapoli in New York; Editing by Maju Samuel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.